Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk IPO'd in 1981 and has grown 32,156% since going public. Trading volume reached 65 million shares, coming in about 283% above its three-month average of 16 million shares. Tuesday's catalysts centered on the FDA's approval of Novo Nordisk's oral Wegovy GLP-1 pill and its broader impact on healthcare stocks, and investors are watching how quickly demand scales in U.S. self-pay channels. The S&P 500 (SNPINDEX:^GSPC) added 0.46% to close at 6,910, while the Nasdaq Composite (NASDAQINDEX:^IXIC) rose 0.57% to finish at 23,562. Pharmaceuticals peers showed mixed moves, with Eli Lilly (NYSE:LLY) slipping 0.5% and Novartis (NYSE:NVS) gaining 1.7%, as investors weighed competitive positioning in obesity treatments. Considering Novo Nordisk is already a leader in the GLP-1 space, today's news that its once-a-day oral Wegovy pill has been approved by the FDA is a significant step in helping the company maintain its leadership position. Management today also detailed plans to la
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lilly, Novo lock horns in India's obesity drug race [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk gets landmark obesity pill approved, with production ‘underway' in NC [Yahoo! Finance]Yahoo! Finance
- Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk says FDA approved Wegovy pill to reduce body weight [Yahoo! Finance]Yahoo! Finance
- Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez [CNBC]CNBC
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website